Pfizer Inc.
US ˙ NYSE ˙ US7170811035

SecurityPFE / Pfizer Inc.
InstitutionPinnacle Bancorp, Inc.
Latest Disclosed Ownership19,384 shares
Latest Disclosed Value $ 544,303
Pinnacle Bancorp, Inc. reports 3.49% decrease in ownership of PFE / Pfizer Inc.

On April 22, 2026 - Pinnacle Bancorp, Inc. filed a 13F-HR form disclosing ownership of 19,384 shares of Pfizer Inc. (US:PFE) valued at $544,303 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 22, 2026 disclosing 20,084 shares of Pfizer Inc.. This represents a change in shares of -3.49% during the quarter. The current value of the position is $491,191 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-22 2026-03-31 13F Pfizer Inc Com COM 717081103 19,384 -700 -3.49 544 8.80 0.1606
2026-01-22 2025-12-31 13F Pfizer Inc Com COM 717081103 20,084 0 0.00 500 -2.15 0.1466
2025-10-24 2025-09-30 13F Pfizer Inc Com COM 717081103 20,084 1,624 8.80 512 14.32 0.1512
2025-07-11 2025-06-30 13F Pfizer Inc Com COM 717081103 18,460 -800 -4.15 447 -8.40 0.1381
2025-04-23 2025-03-31 13F Pfizer Inc Com COM 717081103 19,260 -435 -2.21 488 -6.51 0.1591
2025-01-14 2024-12-31 13F Pfizer Inc Com COM 717081103 19,695 -6,896 -25.93 523 -32.12 0.1699
2024-10-09 2024-09-30 13F Pfizer Inc Com COM 717081103 26,591 84 0.32 770 3.78 0.2057
2024-07-15 2024-06-30 13F Pfizer Inc Com COM 717081103 26,507 -5,402 -16.93 742 -16.27 0.2190
2024-04-16 2024-03-31 13F Pfizer Inc Com COM 717081103 31,909 5,111 19.07 885 14.79 0.2619
2024-01-25 2023-12-31 13F Pfizer Inc Com COM 717081103 26,798 -713 -2.59 772 -15.46 0.2526
2023-10-18 2023-09-30 13F Pfizer Inc Com COM 717081103 27,511 -951 -3.34 913 -12.56 0.3243
2023-07-14 2023-06-30 13F Pfizer Inc Com COM 717081103 28,462 1,735 6.49 1,044 -4.31 0.3570
2023-04-14 2023-03-31 13F Pfizer Inc Com COM 717081103 26,727 78 0.29 1,090 108,900.00 0.4003
2023-01-24 2022-12-31 13F Pfizer Inc Com COM 717081103 26,649 -1,350 -4.82 1 -99.92 0.5251
2022-10-25 2022-09-30 13F Pfizer Inc Com COM 717081103 27,999 -92 -0.33 1,225 -16.84 0.5290
2022-07-12 2022-06-30 13F Pfizer Inc Com COM 717081103 28,091 2,149 8.28 1,473 9.68 0.6061
2022-04-14 2022-03-31 13F Pfizer Inc Com COM 717081103 25,942 -679 -2.55 1,343 -14.57 0.4660
2022-01-19 2021-12-31 13F Pfizer Inc Com COM 717081103 26,621 -6,831 -20.42 1,572 9.24 0.5557
2021-10-12 2021-09-30 13F Pfizer Inc Com COM 717081103 33,452 4,365 15.01 1,439 26.34 0.5754
2021-07-15 2021-06-30 13F Pfizer Inc Com COM 717081103 29,087 -468 -1.58 1,139 6.35 0.5197
2021-04-26 2021-03-31 13F Pfizer Inc Com COM 717081103 29,555 -1,050 -3.43 1,071 -4.97 0.5189
2021-01-13 2020-12-31 13F Pfizer Inc Com COM 717081103 30,605 -359 -1.16 1,127 -0.79 0.6941
2020-10-13 2020-09-30 13F Pfizer Inc Com COM 717081103 30,964 -3,162 -9.27 1,136 1.79 0.8007
2020-07-07 2020-06-30 13F Pfizer Inc Com COM 717081103 34,126 2,547 8.07 1,116 8.24 0.8301
2020-04-09 2020-03-31 13F Pfizer Inc Com COM 717081103 31,579 0 0.00 1,031 -16.65 0.8807
2020-01-10 2019-12-31 13F Pfizer Inc Com COM 717081103 31,579 -279 -0.88 1,237 8.03 0.8571
2019-10-08 2019-09-30 13F Pfizer Inc Com COM 717081103 31,858 -81 -0.25 1,145 -17.27 0.6536
2019-07-08 2019-06-30 13F Pfizer Inc Com COM 717081103 31,939 -350 -1.08 1,384 0.95 0.7779
2019-04-05 2019-03-31 13F Pfizer Inc Com COM 717081103 32,289 -260 -0.80 1,371 -3.52 0.7951
2019-03-20 2018-12-31 13F Pfizer Inc Com COM 717081103 32,549 -126 -0.39 1,421 27.10 0.8740
2017-04-17 2017-03-31 13F Pfizer Inc Com COM 717081103 32,675 32,675 1,118 0.7905
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.